Dark

BLTE
Belite Bio, Inc
stock NASDAQ ADR

At Close

Jul 31, 2026 3:59:53 PM EDT

158.76USD-0.725%(-1.16)159,281

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-159.92)0

After-hours

Jul 31, 2026 4:00:30 PM EDT

158.61USD-0.094%(-0.15)8,120

Overview HistoricalExchangesShortsTrends

open chart

Market Cap

6.37B

Industry

Biotechnology

Next Earnings

Aug 10, 2026 (9d)

BLTE Stats

Avg. Vol. 10 Day

178,838

Avg. Vol. 30 Day

193,950

Market Cap

6,370,723,513

Shares Out.

40,085,091

On/Off Exchange

60%/40%

6 Month Beta

1.18

1 Year Beta

1.01

2 Year Beta

0.56

3 Year Beta

0.60

52 Week Low

60.00

52 Week High

200.00

SMA50

147.87

SMA200

150.06

1 Week

+3.63%

1 Month

+11.68%

3 Month

+2.64%

6 Month

-8.30%

1 Year

+141.83%

2 Year

+227.42%

5 Year

+1,400.76%

Profile

belite bio inc is a san diego based clinical stage biopharmaceutical drug development company targeting untreatable age-related metabolic diseases, including macular degeneration, liver disease and diabetes. developed from our anti-rbp4 technology platform, our lead candidate, lbs-008, is currently in a phase i clinical trial for dry age-related macular degeneration and its juvenile form, stargardt disease. lbs-008 has received orphan drug status in the us and europe, as well as rare pediatric disease status in the us.

BLTE Stock Summary

Belite Bio, Inc (NASDAQ:BLTE) stock price today is $158.76, and today's volume is 159,281. BLTE is down -0.725% today. The 30 day average volume is 193,950. BLTE market cap is 6.37B with 40,085,091 shares outstanding.

.dark-mode .yWqZCg{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .yWqZCg{ color: #333333; background-color: white; border: 2px solid #333333; }BLTEBelite Bio, Incstock NASDAQ ADR

BLTE Stock Summary

BLTE
Belite Bio, Inc
stock NASDAQ ADR